New target explored for psychiatric drug development
In a surprising discovery, neuroscientists, led by a team from Washington University School of Medicine in St. Louis, have found that a molecule that is a breakdown product of cholesterol in the brain may be a target for developing new drugs to treat schizophrenia and other mental illnesses.